Medicine passport

Palexia Retard 50 mg tabletten met verlengde afgifte 50 mg

The same active substance, strength and form as listed by each country’s medicines regulator. For showing a pharmacist abroad.

Active substance
Tapentadolhydrochloride
Strength
50 mg
Form
tablet met verlengde afgifte
ATC code
N02AX06
Registered in
Netherlands · Grünenthal B.V.
Prescription
Prescription only
RVG
110724

Source: Geneesmiddeleninformatiebank · 2026-09-30

Not a prescription. Not a statement that these products are interchangeable. Products are matched on active substance, strength and kind of form only. Other ingredients, release, approved uses and the dose on the box can differ. A pharmacist or doctor decides whether one can replace another.

Listed in other countries

Spain 12 matching products

Name on the boxStrength and formPrescriptionHolderOfficial record
PALEXIA50 mg · comprimido recubierto con películaPrescription onlyGrünenthal Pharma S.A.73242
PALEXIA RETARD50 mg tapentadol · comprimido de liberación prolongadaPrescription onlyGrünenthal Pharma S.A.73243
PALGESIC RETARD50 mg · comprimido de liberación prolongadaPrescription onlyKern Pharma S.L.88334
REMUVA50 mg · comprimido de liberación prolongadaPrescription onlyAristo Pharma Gmbh88300
TAPENTADOL KRKA50 mg · comprimido de liberación prolongadaPrescription onlyKrka D.D. Novo Mesto86287
TAPENTADOL RETARD SANDOZ50 mg · comprimido de liberación prolongadaPrescription onlySandoz Farmaceutica S.A.88309

6 more names not shown. Source: CIMA — Centro de Información online de Medicamentos (Agencia Española de Medicamentos y Productos Sanitarios (AEMPS)) · 2026-09-30 · Fuente: Agencia Española de Medicamentos y Productos Sanitarios (AEMPS), CIMA.

Canada 3 matching products

Name on the boxStrength and formPrescriptionHolderOfficial record
APO-TAPENTADOL50 mg · tablet (immediate-release)Prescription onlyApotex Inc02471965
NUCYNTA EXTENDED-RELEASE50 mg · tablet (extended-release)Prescription onlyKnight Therapeutics Inc.02415577
NUCYNTA IR50 mg · tablet (immediate-release)Prescription onlyKnight Therapeutics Inc.02378272

Source: Drug Product Database (Health Canada) · 2026-09-30 · Contains information licensed under the Open Government Licence – Canada.

Same active substance, but no match for this strength and form

Countries covered: United States, Bulgaria, European Union, Spain, France, Netherlands, Canada, Switzerland. A country missing from the list may still sell this medicine: Mediclarum reads only these registers.

Register data as of 2026-09-30. Mediclarum stores nothing about you for this page. https://www.mediclarum.com/nl/en/medicines/palexia-retard-50-mg-tabletten-met-verlengde-afgifte-50-mg-tablet-met-ve